Actively Recruiting
A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
Led by The First Affiliated Hospital of Xiamen University · Updated on 2025-01-03
110
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand how thumb-tack needle therapy affects sleep and recovery after surgery in patients who have undergone general anesthesia for breast cancer surgery. The study focuses on improving postoperative sleep quality, preventing sleep disorders, and promoting recovery following surgery. Participants are women aged 18 to 55 years with no history of chronic insomnia or recent use of sedative-hypnotic drugs. Participants in this observational study will undergo thumb-tack needle therapy as part of their postoperative care. The therapy's impact will be monitored without assigning different treatment groups. The study will follow patients before and after anesthesia exposure to observe changes in sleep quality and recovery. During the study, researchers will assess sleep quality using the Pittsburgh Sleep Quality Index (PSQI) one or two days before anesthesia and on days 1, 3, and 7 after anesthesia. Recovery will also be evaluated with the QoR-40 questionnaire on the third day after surgery. The study monitors patient progress to explore the clinical significance of thumb-tack needle therapy in improving postoperative outcomes.
CONDITIONS
Brief Title
A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing breast cancer surgery with general anesthesia in the hospital
- American Society of Anesthesiologists (ASA) classification I-II
- Women aged 18 to 55 years
- No history of chronic insomnia
- No use of sedative-hypnotic drugs within the past month
You will not qualify if you...
- Not meeting the inclusion criteria
- History of severe heart, brain, lung, or kidney diseases such as acute coronary syndrome, severe heart failure (NYHA Class III or IV), severe arrhythmias, severe valvular disease, acute aortic disease, or severe peripheral vascular disease
- Poor physical condition including reduced exercise tolerance, multi-organ dysfunction, or malnutrition
- History of sleep disorders or psychiatric illness
- Inability to receive thumb-tack needle treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo breast cancer surgery with general anesthesia in the hospital and receive immediate post-operative care.
1 visit (in-person)
Duration - 7 days
Participants complete assessments of sleep quality and recovery after surgery using questionnaires.
3 visits (in-person) on days 1, 3, and 7 after anesthesia exposure
Trial Site Locations
Total: 2 locations
1
First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China, 361000
Actively Recruiting
2
First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China, 361000
Actively Recruiting
Research Team
B
Bin Yang doctor
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here